id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0011-0003,FDA,FDA-2013-N-0011,Biologics License Applications: Technical Amendment; Change of Address,Rule,Final Rule,2013-04-02T04:00:00Z,2013,4,2013-04-02T04:00:00Z,,2013-04-02T13:49:08Z,2013-07578,0,0,0900006481258fe9
FDA-2013-N-0011-0002,FDA,FDA-2013-N-0011,Medical Devices; Technical Amendments,Rule,Final Rule,2013-03-26T04:00:00Z,2013,3,2013-03-26T04:00:00Z,,2013-03-26T13:21:19Z,2013-06826,0,0,09000064812451d9
FDA-2013-N-0011-0001,FDA,FDA-2013-N-0011,Public Hearing Before a Public Advisory Committee; Technical Amendments,Rule,Final Rule,2013-03-20T04:00:00Z,2013,3,2013-03-20T04:00:00Z,,2013-08-01T15:20:18Z,2013-06354,0,0,090000648123748e